Mylan sees possible conflict with special master in US generic drug pricing case
( September 1, 2026, 22:31 GMT | Official Statement) -- MLex Summary: Mylan asked a US federal judge to stay of proceedings in an antitrust litigation accusing it of illegally conspiring on generic drug prices. Mylan is asking for extra time to investigate through discovery a potential conflict with Special Discovery Master Lawrence F. Stengel that would impact the entire litigation. See attached file. ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.